| Literature DB >> 34993905 |
Richa Jalodia1, Yaa Fosuah Abu1,2, Mark Ryan Oppenheimer1, Bridget Herlihy1, Jingjing Meng1, Irina Chupikova1, Junyi Tao1, Nillu Ghosh1, Rajib Kumar Dutta1, Udhghatri Kolli1, Yan Yan1, Eridania Valdes1, Madhulika Sharma1, Umakant Sharma3, Shamsudheen Moidunny4, Sabita Roy5.
Abstract
Opioid use disorder (OUD) is defined as the chronic use or misuse of prescribed or illicitly obtained opioids and is characterized by clinically significant impairment. The etiology of OUD is multifactorial as it is influenced by genetics, environmental factors, stress response and behavior. Given the profound role of the gut microbiome in health and disease states, in recent years there has been a growing interest to explore interactions between the gut microbiome and the central nervous system as a causal link and potential therapeutic source for OUD. This review describes the role of the gut microbiome and opioid-induced immunopathological disturbances at the gut epithelial surface, which collectively contribute to OUD and perpetuate the vicious cycle of addiction and relapse.Entities:
Keywords: Enteric nervous system; Gut-brain axis; Microbiome; OUD; Opioids
Year: 2022 PMID: 34993905 DOI: 10.1007/s11481-021-10046-z
Source DB: PubMed Journal: J Neuroimmune Pharmacol ISSN: 1557-1890 Impact factor: 4.147